🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 62856H107
- Market Cap
- Micro Cap · $90 Million
- Previous Name
- Myriad Pharmaceutics
Business: Myrexis, Inc. is a biotechnology company focused on discovering, developing, and commercializing novel treatments for cancer. Their pipeline includes clinical and pre-clinical product candidates with distinct mechanisms of action and novel chemical structures that have the potential to be first-in-class and/or best-in-class therapeutics.
Company Contact
- CEO
- Adrian N. Hobden, Ph.D.
- CFO
- Robert J. Lollini
- Headquarters
- 305 Chipeta Way, Salt Lake City, UT 84108
- Phone
- 801-214-7800
- Fax
- 801-214-7992
- Investor Relations
- 801-214-7800